Neovascularization, Pathologic
"Neovascularization, Pathologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
| Descriptor ID |
D009389
|
| MeSH Number(s) |
C23.550.589.500
|
| Concept/Terms |
Neovascularization, Pathologic- Neovascularization, Pathologic
- Pathologic Neovascularization
- Neovascularization, Pathological
- Pathological Neovascularization
- Pathologic Angiogenesis
- Angiogenesis, Pathologic
- Angiogenesis, Pathological
- Pathological Angiogenesis
|
Below are MeSH descriptors whose meaning is more general than "Neovascularization, Pathologic".
Below are MeSH descriptors whose meaning is more specific than "Neovascularization, Pathologic".
This graph shows the total number of publications written about "Neovascularization, Pathologic" by people in this website by year, and whether "Neovascularization, Pathologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 3 | 4 |
| 1999 | 2 | 2 | 4 |
| 2001 | 5 | 1 | 6 |
| 2002 | 3 | 3 | 6 |
| 2003 | 2 | 7 | 9 |
| 2004 | 4 | 0 | 4 |
| 2005 | 2 | 6 | 8 |
| 2006 | 5 | 4 | 9 |
| 2007 | 7 | 3 | 10 |
| 2008 | 5 | 5 | 10 |
| 2009 | 3 | 6 | 9 |
| 2010 | 5 | 6 | 11 |
| 2011 | 4 | 4 | 8 |
| 2012 | 2 | 3 | 5 |
| 2013 | 2 | 2 | 4 |
| 2014 | 4 | 6 | 10 |
| 2015 | 3 | 2 | 5 |
| 2016 | 5 | 6 | 11 |
| 2017 | 6 | 3 | 9 |
| 2018 | 3 | 2 | 5 |
| 2019 | 3 | 4 | 7 |
| 2020 | 3 | 2 | 5 |
| 2021 | 4 | 2 | 6 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neovascularization, Pathologic" by people in Profiles.
-
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis. Cancer Res. 2025 Jan 15; 85(2):299-313.
-
The Roles of Myeloid Cells in Breast Cancer Progression. Adv Exp Med Biol. 2025; 1464:397-412.
-
Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024 Dec 21; 161(1):53.
-
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration. Br J Pharmacol. 2025 Feb; 182(4):951-968.
-
Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone. Cancer Res Commun. 2024 10 01; 4(10):2621-2637.
-
An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axis. J Exp Med. 2024 Oct 07; 221(10).
-
Angiogenesis-Enabled Human Ovarian Tumor Microenvironment-Chip Evaluates Pathophysiology of Platelets in Microcirculation. Adv Healthc Mater. 2024 Jul; 13(19):e2304263.
-
A Mouse Model for Corneal Neovascularization by Alkali Burn. J Vis Exp. 2023 06 30; (196).
-
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy. Clin Cancer Res. 2023 01 04; 29(1):30-39.
-
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy. Angiogenesis. 2023 05; 26(2):279-293.